The Manufacturers Life Insurance Company Boosts Stake in Tempus AI, Inc. (NASDAQ:TEM)

The Manufacturers Life Insurance Company raised its holdings in shares of Tempus AI, Inc. (NASDAQ:TEM) by 10.2% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 29,789 shares of the company’s stock after purchasing an additional 2,765 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Tempus AI were worth $1,686,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of TEM. First Horizon Advisors Inc. bought a new position in Tempus AI in the 3rd quarter worth about $30,000. Vestor Capital LLC purchased a new stake in shares of Tempus AI in the third quarter valued at approximately $153,000. Sandia Investment Management LP bought a new position in Tempus AI in the second quarter worth approximately $136,000. IQ EQ FUND MANAGEMENT IRELAND Ltd purchased a new position in Tempus AI during the 3rd quarter worth $258,000. Finally, Clarus Group Inc. purchased a new position in Tempus AI during the 3rd quarter worth $283,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Analysts Set New Price Targets

TEM has been the topic of a number of recent research reports. Stifel Nicolaus downgraded Tempus AI from a “buy” rating to a “hold” rating and increased their price target for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Bank of America cut shares of Tempus AI from a “buy” rating to a “neutral” rating and increased their target price for the stock from $45.00 to $60.00 in a report on Wednesday, October 2nd. Piper Sandler reissued a “neutral” rating and set a $70.00 target price (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Loop Capital upped their price target on shares of Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a research report on Tuesday, October 15th. Finally, Guggenheim started coverage on shares of Tempus AI in a report on Monday. They set a “buy” rating and a $74.00 price objective on the stock. Three investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, Tempus AI presently has a consensus rating of “Moderate Buy” and an average target price of $56.20.

Tempus AI Trading Down 7.8 %

Tempus AI stock opened at $46.50 on Tuesday. Tempus AI, Inc. has a fifty-two week low of $22.89 and a fifty-two week high of $79.49. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The company’s 50-day moving average price is $53.34.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.